Axela, Thermal Gradient Ink Deal for Technology Integration | GenomeWeb

NEW YORK (GenomeWeb News) – Axela today announced a development deal to integrate Thermal Gradient's rapid PCR technology into Axela's Flow-Thru Chip automated workflow.

Initially, Thermal Gradient's technology will added to Axela's patent pending approach for capturing and quantifying targeted nucleic acids. The workflow is now optimized for formalin-fixed, paraffin-embedded tissue and is designed for use with other specimens, including other biopsy samples, blood, and isolated cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.